New insights into the pathogenesis of mastocytosis: emerging concepts in diagnosis and therapy

P Valent, C Akin, WR Sperr, HP Horny… - Annual Review of …, 2023 - annualreviews.org
Mastocytosis is a heterogeneous group of neoplasms defined by a numerical increase and
accumulation of clonal mast cells (MCs) in various organ systems. The disease may present …

Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management

MM Patnaik, A Tefferi - American journal of hematology, 2022 - Wiley Online Library
Abstract Disease Overview Chronic myelomonocytic leukemia (CMML) is a clonal
hematopoietic stem cell disorder with overlapping features of myelodysplastic syndromes …

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

DA Arber, A Orazi, RP Hasserjian… - Blood, The Journal …, 2022 - ashpublications.org
The classification of myeloid neoplasms and acute leukemias was last updated in 2016
within a collaboration between the World Health Organization (WHO), the Society for …

Relationship between clone metrics and clinical outcome in clonal cytopenia

A Gallì, G Todisco, E Catamo, C Sala… - Blood, The Journal …, 2021 - ashpublications.org
Clonal cytopenia of undetermined significance (CCUS) is associated with an increased risk
of developing a myeloid neoplasm with myelodysplasia (MN). To identify the features of the …

Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management

MM Patnaik, A Tefferi - American journal of hematology, 2020 - Wiley Online Library
Disease overview Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic
stem cell disorder with overlapping features of myelodysplastic syndromes and …

The International Consensus Classification of myelodysplastic syndromes and related entities

RP Hasserjian, A Orazi, A Orfao, M Rozman, SA Wang - Virchows Archiv, 2023 - Springer
Abstract The International Consensus Classification (ICC) of myeloid neoplasms and acute
leukemia has updated the classification of myelodysplastic syndromes (MDSs) and placed …

[HTML][HTML] How I diagnose and treat chronic myelomonocytic leukemia

MM Patnaik - Haematologica, 2022 - ncbi.nlm.nih.gov
Chronic myelomonocytic leukemia (CMML) is a myelodysplastic syndrome/
myeloproliferative overlap neoplasm characterized by sustained peripheral blood …

Advances in myelodysplastic/myeloproliferative neoplasms

S Prakash, DA Arber, C Bueso-Ramos, RP Hasserjian… - Virchows Archiv, 2023 - Springer
The myelodysplastic syndrome/myeloproliferative neoplasms (MDS/MPN) category includes
a heterogeneous group of diseases characterized by the co-occurrence of clinical and …

Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet …

AA van de Loosdrecht, W Kern, A Porwit… - Cytometry Part B …, 2023 - Wiley Online Library
This article discusses the rationale for inclusion of flow cytometry (FCM) in the diagnostic
investigation and evaluation of cytopenias of uncertain origin and suspected …

Pharmacogenomics of impaired tyrosine kinase inhibitor response: lessons learned from chronic myelogenous leukemia

M Kaehler, I Cascorbi - Frontiers in Pharmacology, 2021 - frontiersin.org
The use of small molecules became one key cornerstone of targeted anti-cancer therapy.
Among them, tyrosine kinase inhibitors (TKIs) are especially important, as they were the first …